Green Room Technologies Ideas

Green Room Technologies | Established Tech
Industry News

What’s ahead for digital health in 2021?

Now what? With 2020 in the rearview mirror we break down the forces that will shape the trajectory of digital health over the next twelve months. We explore four themes that will impact digital health this year.

To kick off the new year, we are reflecting on the profound impact that the last twelve months will have on the next twelve for digital health. Although 2020’s tumultuous events—a global pandemic and social and political tension—have not resolved, we’re encouraged by the opportunity we see for digital health in 2021. This trajectory is shaped by three forces:

Read More »
Health.Market
Health.Market

Health.Market January 11, 2021

Last week for stocks was more or less a continuation of what had happened from November onward. One hopes with resolution of some things we could just settle down some. But when money meets momentum, keep your seatbelts fastened. Going in either direction.

Read More »
Health.Market
Health.Market

Health.Market December 21, 2020

Activity is slowing down and continuation patterns proliferate. NDX is more bullish than SPX. SPX sectors are sideways to mild correction except XLK, XLY +/- XLV. It’s time to let 2020 be – sans a new disaster. Enjoy the season and come back to it in 2021.

Read More »
Green Room Technologies | Digital Health
Industry News

Next-gen digital health innovation in clinical trials

There has been an explosion of digital health innovation in clinical trials. The Rock Health Consulting team explores this evolution and what the next horizon will bring to clinical trials.

In a world of on-demand everything the biopharma R&D cycle is an anomaly: drugs require an average of 10 to 15 years to progress from discovery to FDA approval, and an average investment of $2.6 billion across the development lifecycle. Never has that lengthy process been felt so acutely than when the world waited on edge while academic institutions, government agencies, and pharmaceutical companies raced to develop a COVID-19 vaccine in record time.

Read More »
Health.Market
Health.Market

Health.Market December 14, 2020

Momentum declined last week and with net bullish sentiment is not a great setup for further gains short term. The indexes are overbought but not excessively so and appear to be internally correcting. The peak may have coincided with the two IPO’s this week that were extreme. Next market movers: momentum + pandemic + earnings.

Read More »
Health.Market
Health.Market

Health.Market December 7, 2020

Last week was very bullish for stocks. We are reaching the tops of technical ranges but have not yet established extreme overbought conditions, which as we all know can last for long periods especially in raging momentum markets like what we have now. If “raging” was a stock it would be ripe for a correction.

Read More »
Health.Market
Health.Market

Health.Market November 30, 2020

Although it is difficult to make very strong conclusions on a holiday week the market remains very bullish and became more so last week. The healthcare sector has been mildly correcting for a while and underperforming the broader market. Technicals suggest this may change soon. Stay tuned.

Read More »
Health.Market
Health.Market

Health.Market November 23, 2020

We are still mostly in a momentum market and disconnected from actual occurrences. There are a couple very strong market price support mechanisms in play likely limiting downside: Fed policies and progress on vaccines. Whether we rocket higher or not seems not that likely to me, but if the progress on vaccines accelerates, it could happen. Maybe that would give better visibility and an upward bias to healthcare.

Read More »
Health.Market
Health.Market

Health.Market November 16, 2020

The market is bullish by just about any parameter you can put up. This, of course, in the teeth of the new surge in Covid-19 of uncertain impact but not expected to be good. It seems to me we have somewhere between 2 and 6 months before we start seeing real positive impact on the virus by whatever means. And longer for measurable vaccine impact. The markets may or may not care.

Read More »
Health.Market
Health.Market

Health.Market November 9, 2020

We have some vaccine news and we have positive seasonal expectations. We continue to follow the Age of Covid market story. This is driven by companies that are doing well + vaccine and treatments for Covid available sometime in the future + Fed’s monetary policy +/- Congress doing something…anything. 

Read More »
Green Room Technologies | Turning Good Ideas Into Good Business

Meeting Request

By providing your contact information you consent to receiving emails & information from Green Room Technologies. No Spam. We respect your privacy & you may unsubscribe at any time. You must confirm your email prior to any additional emails being sent to the above email address.

PO Box 637
Austin, Texas
[email protected]

By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.